معرفی
Shusaku Mizukami is an Associate Professor at the Department of Immunopathogenesis, Shionogi Global Infectious Diseases Division, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Japan. His research focuses on immunological analysis, vaccine development, and antimalarial drug discovery for tropical diseases.
- Education:
- Doctor of Medicine (2002), Nagasaki University
- Ph.D. in Medical Sciences (2008), Nagasaki University Graduate School
Research Themes: Dr. Mizukami's work primarily addresses malaria vaccine development using mRNA-containing lipid nanoparticles, screening natural products (e.g., Morinda species, Coptis rhizome) for antimalarial and antiviral activities, and immunological mechanisms in dengue and Chagas disease. His 2D-QSAR modeling contributes to rational drug design targeting hemozoin inhibition.
Recent Trends: His publications from 2020–2025 highlight CD8+ T cell dynamics in dengue, liver-targeted vaccines, and computational drug screening for parasitic diseases. Collaborations with Japan Society for the Promotion of Science and AMED grants emphasize innovative vaccine platforms and iPS cell-derived dendritic cell models.
- Scientific Awards:
- Young Researcher Encouragement Award, Japanese Society of Cancer Immunology (2010)
Academic Impact: As a principal investigator, he leads malaria vaccine projects and dengue immunology studies. His work bridges basic immunology with translational research in Southeast Asia, Africa, and Japan.
